Research in the Tumor Imaging Program extends from imaging in animals geared towards helping expand our understanding of cancer biology, to the use of medical imaging on the diagnosis and assessment of response to therapy of tumors. The overall goal of the members of this program is to develop new approaches to use medical imaging in cancer research and to extend current imaging capabilities to optimize diagnosis and assessment of response to therapy. There are five major overlapping themes within the umbrella of the Program's research. Theme 1 - Diagnostic Imaging Theme 2 - Assessment of Response to Therapy by Imaging Theme 3 - Reporter Gene Imaging Theme 4 - Imaging Parameters Indicative of Metabolic Oxidative Stress Theme 5 - Imaging of Cell Trafficking Major accomplishments of the Tumor Imaging Program include (a) Discovery that 2DG-induced radiosensitization involved disruptions in thiol metabolism supporting the hypothesis that metabolic oxidative stress could be involved with the therapeutic effects of 2DG during cancer therapy, (b) Discovery that gene therapy using an adenovirus vector containing a cDNA coding for the sodium iodide symporter could be utilized to concentrate radionuclides in tumors, and (c) Significant contributions to our understanding of lung cancer diagnosis extending from development of novel approaches to lung cancer imaging through extensive participation in the lung cancer early detection trial. There are numerous past and present productive collaborations both between members of the Program, and with members of other Cancer Center programs. The interactive nature of the Program is illustrated by the """"""""Molecular Imaging of Responses to Cancer Therapy"""""""" program supported by an NCI P20 and successful shared instrumentation grants to obtain a Micro- PET machine and SPECT-CT. The program consists of 25 members from 7 departments and 2 colleges. Peer-reviewed, research funding for this program totals $5,878,362 with $1,486,243 coming from the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-10
Application #
7900744
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$22,489
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Kim, Yusung; Cabel, Katherine; Sun, Wenqing (2018) Does the apex optimization line matter for single-channel vaginal cylinder brachytherapy planning? J Appl Clin Med Phys 19:307-312
Hagan, Teresa L; Gilbertson-White, Stephanie; Cohen, Susan M et al. (2018) Symptom Burden and Self-Advocacy: Exploring the Relationship Among Female Cancer Survivors?. Clin J Oncol Nurs 22:E23-E30
Chesney, Jason; Puzanov, Igor; Collichio, Frances et al. (2018) Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma. J Clin Oncol 36:1658-1667
Brooks, Jennifer D; Comen, Elizabeth A; Reiner, Anne S et al. (2018) CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study. Breast Cancer Res 20:149
Chioreso, Catherine; Del Vecchio, Natalie; Schweizer, Marin L et al. (2018) Association Between Hospital and Surgeon Volume and Rectal Cancer Surgery Outcomes in Patients With Rectal Cancer Treated Since 2000: Systematic Literature Review and Meta-analysis. Dis Colon Rectum 61:1320-1332
Musselman, Catherine A; Kutateladze, Tatiana G (2018) A histone reader becomes the readout. J Biol Chem 293:7486-7487
Merritt, Nicole M; Fullenkamp, Colleen A; Hall, Sarah L et al. (2018) A comprehensive evaluation of Hippo pathway silencing in sarcomas. Oncotarget 9:31620-31636
Haskins, Cole B; McDowell, Bradley D; Carnahan, Ryan M et al. (2018) Impact of preexisting mental illness on breast cancer endocrine therapy adherence. Breast Cancer Res Treat :
Daneshmand, Siamak; Patel, Sanjay; Lotan, Yair et al. (2018) Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study. J Urol 199:1158-1165
Borcherding, Nicholas; Kolb, Ryan; Gullicksrud, Jodi et al. (2018) Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer. J Mol Biol 430:2014-2029

Showing the most recent 10 out of 1080 publications